StonvexLoading…
StonvexStonvexStonvexCore line items from MNTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.21M | $1.11M | $747.00K | $513.00K |
Operating Income | $-8.69M | $-27.25M | $-18.38M | $-12.13M |
Net Income | $-9.48M | $-30.47M | $-23.70M | $-6.45M |
EPS (Diluted) | $-2.15 | $-49.10 | $-3.68 | $-2.81 |
Total Assets | $45.86M | $40.32M | $19.60M | $9.19M |
Total Liabilities | $18.70M | $23.18M | $20.30M | $19.16M |
Cash & Equivalents | $23.48M | $12.81M | $670.00K | $132.00K |
Free Cash Flow OCF − CapEx | $-6.01M | $-23.29M | Not available | Not available |
Shares Outstanding | 4.40M | 622.94K | 6.45M | 4.50M |